Literature DB >> 9402645

The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra.

A D Crocker1.   

Abstract

The importance of the nigrostriatal dopaminergic pathway in motor control is widely accepted and it is generally believed that the motor symptoms of Parkinson's disease result solely from reduced release of dopamine from terminals in the striatum. Over recent years there has been a growing body of evidence which suggests that dendritic dopamine release in the substantia nigra is of importance in the regulation of neuronal activity and behaviour. This evidence is reviewed together with a description of our recent findings that show nigral dopamine receptors are essential for the maintenance of normal muscle tone. It is concluded that current views of the basal ganglia circuitry involved in motor control need to be re-evaluated to take into account these recent reports. A scheme is suggested to explain how dopamine mechanisms in the substantia nigra regulate motor activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402645     DOI: 10.1515/revneuro.1997.8.1.55

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  17 in total

1.  Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol.

Authors:  William S Cobb; Elizabeth D Abercrombie
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

Review 2.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

3.  Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California.

Authors:  Dalin Li; Stephanie J London; Jinghua Liu; Wonho Lee; Xuejuan Jiang; David Van Den Berg; Andrew W Bergen; Denise Nishita; Nahid Waleh; Gary E Swan; Peggy Gallaher; Chih-Ping Chou; Jean C Shih; Jennifer B Unger; W James Gauderman; Frank Gilliland; C Anderson Johnson; David V Conti
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

4.  Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.

Authors:  B T Chen; M E Rice
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.

Authors:  Jyoti C Patel; Paul Witkovsky; Marat V Avshalumov; Margaret E Rice
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

6.  Cross-hemispheric dopamine projections have functional significance.

Authors:  Megan E Fox; Maria A Mikhailova; Caroline E Bass; Pavel Takmakov; Raul R Gainetdinov; Evgeny A Budygin; R Mark Wightman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

7.  Significance of DopEcR, a G-protein coupled dopamine/ecdysteroid receptor, in physiological and behavioral response to stressors.

Authors:  Emily Petruccelli; Arianna Lark; James A Mrkvicka; Toshihiro Kitamoto
Journal:  J Neurogenet       Date:  2020-01-20       Impact factor: 1.250

Review 8.  Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.

Authors:  Dénes Zádori; Levente Szalárdy; József Toldi; Ferenc Fülöp; Péter Klivényi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-11-30       Impact factor: 3.575

9.  Female mice are resilient to age-related decline of substantia nigra dopamine neuron firing parameters.

Authors:  Rebecca D Howell; Sergio Dominguez-Lopez; Sarah R Ocañas; Willard M Freeman; Michael J Beckstead
Journal:  Neurobiol Aging       Date:  2020-08-03       Impact factor: 4.673

Review 10.  Dopamine release in the basal ganglia.

Authors:  M E Rice; J C Patel; S J Cragg
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.